More importantly, AD-MSCs could downregulate the expression of Nrf2 in HSFs, resulting in a reduction in the expression of antioxidant enzymes and an accumulation of intracellular ROS, eventually activating the apoptosis program. The gene discussed is NFE2L2; the disease is Alzheimer disease.